Journal details
DRUG METABOLISM REVIEWS
TAYLOR & FRANCIS LTD · ISSN 0360-2532 · eISSN 1097-9883
SCIEScopusMEDLINEPubMedPMC
Overview
DRUG METABOLISM REVIEWS. ISSN 0360-2532 · eISSN 1097-9883. published by TAYLOR & FRANCIS LTD. United States. Pharmacology & Pharmacy. impact factor 4.7 (2025). JCR Q1. CAS Zone 3. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 15 articles · 2025: 25 articles · 2024: 24 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of DRUG METABOLISM REVIEWS?
The impact factor recorded for DRUG METABOLISM REVIEWS is 4.7 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of DRUG METABOLISM REVIEWS?
DRUG METABOLISM REVIEWS is listed in CAS Zone 3.
Which databases index DRUG METABOLISM REVIEWS?
DRUG METABOLISM REVIEWS is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.